Will absorbable metal stent technology change our practice?

Journal of Cardiovascular Surgery

Volumn 47, Issue 4, 2006, Pages 393-397

  Bosiers, Marc ^a   Deloose, K ^a   Verbist, J ^b   Peeters, P ^b  

^a AZ St Blasius ^*  (Belgium)

^b IMELDA HOSPITAL   (Belgium)

Author keywords

Ischemia; Limb; Stents

Indexed keywords

ALLOY; MAGNESIUM; PACLITAXEL; RAPAMYCIN;

ABSORBABLE METAL STENT; AMPUTATION; ARTERY DISEASE; ARTERY INTIMA PROLIFERATION; ARTERY OCCLUSION; ARTICLE; BIOCOMPATIBILITY; CLINICAL TRIAL; DRUG ELUTING STENT; ENDOVASCULAR SURGERY; HEALTH CARE COST; HUMAN; LEG REVASCULARIZATION; LIMB ISCHEMIA; LIMB SALVAGE; MEDICAL TECHNOLOGY; MINIMALLY INVASIVE SURGERY; NONHUMAN; REVASCULARIZATION; STENT; TREATMENT OUTCOME; VASCULAR PATENCY;

ABSORBABLE IMPLANTS; BLOOD VESSEL PROSTHESIS IMPLANTATION; COATED MATERIALS, BIOCOMPATIBLE; HUMANS; ISCHEMIA; LEG; METALS; PROSTHESIS DESIGN; STENTS;

EID: 33749046079     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Jaff M, Biamino G. Conquering critical limb ischemia: do you know the dangers your patients face, and are you prepared tot treat them? Today's therapeutic advances are changing the way we evaluate and treat this common and often fatal disorder. Endovascular Today 2004;3:45-8.
2. TASC working group. Treatment of critical limb ischemia. J Vasc Surg 2000;31:S192-S295.
3. Allie DE, Hebert C, Lirtzman MD, Wyatt CH, Keller AV, Khan MH et al. Critical limb ischemia: a global epidemic. A critical analysis of current treatment unmasks the clinical and economic costs of CLI. Eurointerventions 2005;1:75-84.
4. Wolfe JH, Wyatt MG. Critical and subcritical ischaemia. Eur J Vasc Endovasc Surg 1997;13:578-82.
5. Goshima KR, Mills JL Sr, Hughes JD. A new look at outcomes after infrainguinal bypass surgery: traditional reporting standards systematically underestimate the expenditure of effort required to attain limb salvage. J Vasc Surg 2004;39:330-5.
6. Bosiers M, Hart JP, Deloose K, Verbist J, Peeters P. Endovascular therapy as the primary approach for limb salvage in patients with critical limb ischemia: experience with 443 infrapopliteal procedures. Vascular 2006;14:1-5
7. Duda SH, Bosiers M, Lammer J, Scheinert D, Zeller T, Tielbeek A. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol 2005;16:331-8.
8. Griffiths H, Peeters P, Verbist J, Bosiers M, Deloose K, Heublein B. Future device: bioabsorbable stents. Br J Cardiol 2004;11:80-4.
9. Peeters P, Bosiers M, Verbist J, Deloose K, Heublein B. Preliminary results after application of absorbable metal stems in patients with critical limb ischemia. J Endovasc Ther 2005;12:1-5.
10. Tamai H, Igaki K, Kyo E, Kosuga K, Kawashima A, Matsui S et al. Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans. Circulation 2000;102:399-404.
11. Tsuji T, Tamai H, Igaki K, Kyo E, Kosuga K, Hata T et al. Biodegradable stents as a platform to drug loading. Int J Cardiovasc Intervent 2003;5:13-6.
12. Tsuji T, Tamai H, Igaki K, Kyo E, Kosuga K, Hata T et al. Biodegradable Polymeric Stents. Curr Interv Cardiol Rep 2001;3:10-7.